September 24, 2024

Individualized pretest risk estimates to guide treatment decisions in patients with clinical high risk for psychotic disorders

Publications /

Individualized pretest risk estimates to guide treatment decisions inpatients with clinical high risk for psychotic disorders Elodie Sprüngli-Toffel,  … , Stefan Borgwardt, Christina Andreou DOI: 10.1016/j.sjpmh.2024.09.001   Abstract Introduction: Clinical high risk for psychosis (CHR) states are associated with an increased risk of transition to psychosis. However, the predictive value of CHR screening interviews is […]

Individualized pretest risk estimates to guide treatment decisions in patients with clinical high risk for psychotic disorders Read More »

Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine

Publications /

Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine Mihai Avram, …, Alexandra Korda, …, Helena Rogg, …, Stefan Borgwardt  DOI: 10.1038/s41380-024-02734-y   Abstract Psychedelics have recently attracted significant attention for their potential to mitigate symptoms associated with various psychiatric disorders. However, the precise neurobiological mechanisms responsible for these effects

Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine Read More »

Scroll to Top